BioVaxys Technology Corp.
BioVaxys Technology Corp.
BioVaxys Technology Corp. est une société d'immunothérapie au stade clinique développant des plates-formes vaccinales contre le SRAS-CoV-2 et divers cancers.
BioVaxys Technology Corp. (BIOV)
BioVaxys Technology Corp. (BIOV)
*Note: Bid Size and Ask Size fields are displayed as actual quantities
*Note: Bid Size and Ask Size fields are displayed as actual quantities
*Note: Bid Size and Ask Size fields are displayed as actual quantities
*Note: Bid Size and Ask Size fields are displayed as actual quantities
Courtier Bid | Quantité demandé | Cours acheteur | Cours vendeur | Quantité offerte | Demandez Broker |
---|---|---|---|---|---|
CIBC World Markets Inc. | 50,000 | 0.035 | 0.04 | 70,000 | Anonymous |
TD Securities Inc. | 1,000 | 0.035 | 0.045 | 90,000 | CIBC World Markets Inc. |
Questrade Inc. | 50,000 | 0.035 | 0.045 | 20,000 | Scotia Capital Inc. |
Questrade Inc. | 11,000 | 0.035 | 0.045 | 40,000 | TD Securities Inc. |
CIBC World Markets Inc. | 100,000 | 0.035 | 0.045 | 40,000 | TD Securities Inc. |
TD Securities Inc. | 100,000 | 0.035 | 0.045 | 20,000 | Questrade Inc. |
TD Securities Inc. | 20,000 | 0.035 | 0.045 | 1,000 | National Bank Financial Inc. |
Anonymous | 1,000 | 0.035 | 0.045 | 1,000 | National Bank Financial Inc. |
TD Securities Inc. | 5,000 | 0.035 | 0.045 | 1,000 | National Bank Financial Inc. |
RBC Capital Markets | 25,000 | 0.035 | 0.045 | 1,000 | National Bank Financial Inc. |
Courtier Bid | Quantité demandé | Cours acheteur | Cours vendeur | Quantité offerte | Demandez Broker |
---|---|---|---|---|---|
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 | ||
0 | 0.00 | 0.00 | 0 |
Acheteur | Quantité demandé | Cours acheteur | Cours vendeur | Quantité offerte | Vendeur |
---|---|---|---|---|---|
20 | 505,000 | 0.035 | 0.04 | 70,000 | 1 |
11 | 191,000 | 0.03 | 0.045 | 277,000 | 11 |
5 | 241,000 | 0.025 | 0.05 | 522,000 | 13 |
5 | 141,000 | 0.02 | 0.055 | 215,000 | 7 |
2 | 201,000 | 0.015 | 0.06 | 46,000 | 7 |
Acheteur | Quantité demandé | Cours acheteur | Cours vendeur | Quantité offerte | Vendeur |
---|---|---|---|---|---|
0 | 0 | 0.00 | 0.00 | 0 | 0 |
0 | 0 | 0.00 | 0.00 | 0 | 0 |
0 | 0 | 0.00 | 0.00 | 0 | 0 |
0 | 0 | 0.00 | 0.00 | 0 | 0 |
0 | 0 | 0.00 | 0.00 | 0 | 0 |
Date/Heure | Prix | Modifier | Volume | Acheteur | Vendeur | Venue |
---|---|---|---|---|---|---|
Apr 25, 19:59 | 0.04 | 0.00 | 1,000 | CIBC World Markets Inc. | Anonymous | CSE |
Apr 25, 19:59 | 0.04 | 0.00 | 1,000 | National Bank Financial Inc. | Anonymous | CSE |
Apr 25, 19:58 | 0.04 | 0.00 | 5,000 | CIBC World Markets Inc. | Anonymous | CSE |
Apr 25, 19:52 | 0.04 | 0.00 | 7,000 | National Bank Financial Inc. | Anonymous | CSE |
Apr 25, 19:52 | 0.04 | 0.00 | 10,000 | National Bank Financial Inc. | Anonymous | CSE |
Information d'entreprise
SEDAR Information
Information d'entreprise
Capitalisation
Company Officers
Bulletins
2024-0715 - Réintégration - BioVaxys Technology Corp. (BIOV)
le 16 juillet/July 2024
Effective immediately, BioVaxys Technology Corp. will be reinstated for trading.
The Company has rectified the situation that gave rise to the suspension.
____________________________
Avec effet immédiat, BioVaxys Technology Corp. sera réintégrée à la négociation.
La Société a rectifié la situation qui a donné lieu à la suspension.